Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

Published Date: 18 Dec 2023

HIF-2 inhibitor recommended for patients who show improvement following anti-VEGF and immunotherapy.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Effect of Common Steroids on Cancer Treatments.

2.

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

3.

Improved end-of-life conversations for cancer patients are identified by a new study.

4.

Exercise may help breast cancer survivors manage weight

5.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot